Stock Market News

Beam Therapeutics stock soars on positive BEAM-302 trial data

Mar 10, 2025 - 12:40
 0
Beam Therapeutics stock soars on positive BEAM-302 trial data
Read More

Tags:

Previous Article

UK's Assura shares rise on $2.08 billion bid from KKR, Stonepeak

Next Article

GDP matters more to stocks than yields, RBC's Calvasina says

Related Posts

EU content law incompatible with U.S. free speech tradition, says FCC's Carr

EU content law incompatible with U.S. free speech tradi...

Mar 3, 2025  0

EU open to tariff negotiations with US, won't compromise on regulation rights - senior legislator

EU open to tariff negotiations with US, won't compromis...

Feb 14, 2025  0

Elon Musk to attend Trump's first official cabinet meeting

Elon Musk to attend Trump's first official cabinet meeting

Feb 25, 2025  0